Videos

Richard Haupt, MD, MPH, discusses what would be required to adequately implement the delivery of a future C. diff vaccine.

Robert Bransfield, MD, DLFAPA, discusses research that explores how some infectious diseases can make individuals homicidal.

Barley Chironda, RPN, CIC, explains what the “chain of infection” is and what is needed to break it.

Leonard Sigal, MD, explains the potential adverse consequences of long-term antibiotic therapy.

Dr. Richard Vickers, explains how antibiotics used to treat C. diff also damage the microbiome.

William Schaffner, MD explains why pregnant women should get vaccinated against flu.

Robert Bransfield, MD, DLFAPA, discusses how to bridge the gap between psychiatrists and infectious disease physicians.

Edmond Hooker, MD, DrPH, discusses the use of a launderable mattress cover to reduce C. diff rates in hospitals.

William Schaffner, MD, explains why dogs cannot catch flu from humans.

Richard Haupt, MD, MPH, sheds light on the Clostridium difficile Vaccine Efficacy Trial (CLOVER).

Daniel Diekema, MD, explains how clinicians can actively work to prevent pathogen spread in their health care facilities.

Pedro Cahn, MD, describes the risk associated with raltegravir HD.

Leonard Sigal, MD, explains why Lyme disease is sometimes overdiagnosed or overtreated.

William Schaffner, MD, discusses efforts to develop a universal flu vaccine.

Dr. Richard Vickers, explains what makes ridinilazole unique.

Michael Edmond, MD, MPH, MPA, stresses that a collaborative effort is needed to control C. difficile in hospitals.

Pedro Cahn, MD, explains who the target population is for raltegravir HD.

Richard Haupt, MD, MPH, discusses the process for developing a vaccine.

Robert Bransfield, MD, DLFAPA, explains how psychoneuroimmunology can work to bridge the gap between psychiatrists and infectious disease physicians to improve patient care.

Edmond Hooker, MD, DrPH, explains how regulatory agencies are “turning a blind eye” to an important issue experienced in hospitals everywhere.

William Schaffner, MD, explains the strengths and weaknesses of the flu vaccine.

Daniel Diekema, MD, describes recent developments made in rapid and molecular diagnostic testing in the microbiology lab, and how these tests strengthen infection prevention efforts.

Dr. Richard Vickers explains how recurrent infection is an unmet medical need when it comes to C. difficile.

Richard Haupt, MD, MPH, discusses the different pharmaceutical companies’ efforts to develop a C. difficile vaccine.

Michael Edmond, MD, MPH, MPA, explains who is in charge of leading infection control programs in hospitals.

Pedro Cahn, MD, shares the results found after 96-weeks of follow-up for the onceMRK Phase 3 clinical trial.

William Schaffner, MD, shares stories to motivate patients and health care providers to receive the flu vaccine.

Jake Glaser describes how recent advances against HIV & AIDS have affected the philanthropic community.

Richard Haupt, MD, MPH, explains how Pfizer is addressing the need for a C. difficile vaccine.

Robert Bransfield, MD, DLFAPA, discusses direct methods that can be used to acquire statistics related to suicides that are a result of Lyme and associated diseases.